TEVA 5313 Pill — WHITE OVAL, 18mm — Ciprofloxacin
| Imprint | TEVA / 5313 |
|---|---|
| Colour | WHITE |
| Shape | OVAL |
| Size | 18 |
| Strength | CIPROFLOXACIN HYDROCHLORIDE 750 mg |
| Dosage form | Tablet, Film Coated |
| Manufacturer | Teva Pharmaceuticals USA, Inc. |
| NDC | 0172-5313 |
| Schedule | — |
| Availability | — |
| Ingredients | CIPROFLOXACIN HYDROCHLORIDE[CIPROFLOXACIN] |
What does this imprint mean?
The imprint "TEVA 5313" is a code stamped or printed on the tablet or capsule by the manufacturer, used to identify the drug, its strength and the maker.
Active ingredient
Ciprofloxacin
Uses and warnings
BOXED WARNING: BOXED WARNING: Fluoroquinolones including ciprofloxacin are "associated with disabling and potentially irreversible serious adverse reactions" including tendinitis/tendon rupture, peripheral neuropathy, and central nervous system effects occurring together. The drug may exacerbate muscle weakness in myasthenia gravis patients and should be avoided in that population. Key Warnings: - Discontinue immediately upon experiencing serious adverse reactions - Risk of tendon rupture (especially Achilles tendon), particularly in patients over 60, on corticosteroids, or with organ transplants - Peripheral neuropathy with potentially irreversible symptoms - CNS effects: psychiatric reactions, seizures, hallucinations, depression with suicidal ideation - Serious hypersensitivity/anaphylactic reactions possible - Hepatotoxicity including fatal hepatic failure reported - QT interval prolongation and torsade de pointes risk - Aortic aneurysm and dissection risk in elderly patients - C. difficile-associated diarrhea possible | BOXED WARNING: Fluoroquinolones including ciprofloxacin are "associated with disabling and potentially irreversible serious adverse reactions" including tendinitis/tendon rupture, peripheral neuropathy, and central nervous system effects occurring together. The drug may exacerbate muscle weakness in myasthenia gravis patients and should be avoided in that population. Key Warnings: - Discontinue immediately upon experiencing serious adverse reactions - Ris
Ciprofloxacin tablets are a fluoroquinolone antibacterial indicated in adults (18+ years) and select pediatric patients for treating infections including: skin/skin structure infections, bone and joint infections, complicated intra-abdominal infections, infectious diarrhea, typhoid fever, uncomplicated gonorrhea, inhalational anthrax post-exposure, plague, chronic bacterial prostatitis, lower respiratory tract infections, urinary tract infections, and acute sinusitis. The label emphasizes reserving use for patients with no alternative treatment options for certain conditions like acute uncomplicated cystitis and acute bronchitis exacerbations due to serious adverse risks.
How to identify this pill
- • Check the imprint matches exactly: "TEVA 5313".
- • Confirm the colour (WHITE) and shape (OVAL).
- • Compare the size (18) against a ruler if possible.
- • When in doubt, confirm with a pharmacist before taking any medication.
Similar-looking pills
IP 272
WHITE OVAL · Sulfamethoxazole Trimethoprim
69 Z
WHITE OVAL · Metformin
I49
WHITE OVAL · Divalproex
KU 181
WHITE OVAL · Pantoprazole
APO ATV40
WHITE OVAL · Atorvastatin
E124
WHITE OVAL · Hydrochlorothiazide
750 C287
WHITE OVAL · Levofloxacin
3169 V
WHITE OVAL · Furosemide
N947 800
WHITE OVAL · Acyclovir
GG C9
WHITE OVAL · Clarithromycin
H 49
WHITE OVAL · Sulfamethoxazole Trimethoprim
L612
WHITE OVAL · Loratadine
Other pills of Ciprofloxacin
CR 500
WHITE ROUND · Ciprofloxacin
R 126
WHITE OVAL · Ciprofloxacin
R 127
WHITE OVAL · Ciprofloxacin
R 127
WHITE OVAL · Ciprofloxacin
CTI 223
WHITE OVAL · Ciprofloxacin
P 250
WHITE ROUND · Ciprofloxacin
G CF
WHITE OVAL · Ciprofloxacin
P 250
WHITE ROUND · Ciprofloxacin
G CF
WHITE OVAL · Ciprofloxacin
C 94
WHITE CAPSULE · Ciprofloxacin
TEVA 5311
WHITE OVAL · Ciprofloxacin
R 127
WHITE OVAL · Ciprofloxacin
Official references
Source: FDA Structured Product Label via NLM Pillbox archive (retired 2021); source file 83be2808-03eb-4bcc-9bf6-6b00cb75252a.xml